Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Lee Oliver Insider Profile
4 Followers
Robert Lee Oliver, Director at PsyBio Therapeutics, holds 1.37M shares in PsyBio Therapeutics (Ticker: TSE:PSYB.H). Most recently, Robert Lee Oliver Bought C$1,365,800 shares of PsyBio Therapeutics on Jan 16, 2023 for an estimated value of 68.29K.
Robert Lee Oliver has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Robert Lee Oliver's holdings
Insider Roles
Director
Roles that Robert Lee Oliver holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Robert Lee Oliver
Robert Lee Oliver's Trading History
List of latest transactions for each holding click on a transaction to see Robert Lee Oliver's performance on stock
You May Also Like
Robert Lee Oliver insider profile FAQ
What is the percentage of profitable transactions made by Robert Lee Oliver?
The percentage of profitable transactions made by Robert Lee Oliver is ―.
What is the average return per transaction made by Robert Lee Oliver?
The average return per transaction made by Robert Lee Oliver is ―.
What stocks does Robert Lee Oliver hold?
Robert Lee Oliver holds: TSE:PSYB.H stocks.
What was Robert Lee Oliver’s latest transaction?
Robert Lee Oliver latest transaction was an Informative Buy of C$68.29K.
What was Robert Lee Oliver's most profitable transaction?
Robert Lee Oliver’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Robert Lee Oliver's role in PsyBio Therapeutics?
Robert Lee Oliver's role in PsyBio Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.